Artificial hearts that could provide a lifeline for people suffering from heart problems are about to go on sale in Europe after receiving regulatory approval from relevant authorities.
Developed by a French company named Carmat, the technology known as Aeson will be available for purchase in the second quarter of 2021.
ALSO READ
Beware of This Fake WhatsApp Targeting iPhone Users
The device is smartly designed to mimic the biological characteristics and movements of a normal heart. Weighing 900g and powered by batteries, the artificial heart perfectly mirrors a mechanical pump for blood circulation.
Carmat’s CEO Stéphane Piat discussed with Reuters his organization’s motives behind designing such a device, saying:
The idea behind this heart, which was born nearly 30 years ago, was to create a device that would replace heart transplants, a device that works physiologically like a human heart, one that’s pulsating, self-regulated, and compatible with blood.
ALSO READ
TikTok Videos & Trespassing Among Reasons Behind Train Accidents: Experts
According to a recent report published in France, the device is designed to replace a real heart for years in patients suffering from end-stage biventricular heart failure.
For now, it has only been approved as a temporary implant for patients awaiting a heart transplant.